Free cookie consent management tool by TermsFeed Policy Generator

25 Years of Forward Thinking

I’m proud to share Fresenius Medical Care’s 2021 Annual Medical Report. We have an incredibly unique opportunity to transform an area of medicine where we can have a global impact on patients’ lives in communities around the world.

The shared experience of COVID-19 has been very unusual for everyone. And the pandemiccontinues to pose considerable challenges for society and healthcare systems worldwide. As a leading healthcare provider for people living with kidney disease, we look after one of the most vulnerable patient populations, and our priority remains their safety and well-being.

As a leader in value based care, we also understand that continuously delivering on this commitment means taking care delivery to a higher level. That requires interpreting science and medical practice patterns on a global basis and driving medical outcomes across the regions. With our Global Medical Office, we ensure that we harness the full potential of our vertically integrated approach to achieve the best clinical outcomes for the patients we serve, their families, and the payor community.

Our 2021 Annual Medical Report highlights the ongoing leadership and commitment of our Global Medical Office in advancing our company’s clinical and scientific strategy on behalf of the patients we serve around the world.

And taking care is a team effort. I am grateful to every Fresenius Medical Care employee who delivers on our promise to create a future worth living for our patients, worldwide, every day.

Chief Executive Officer
Chairman of the Management Board





Explore the 2021 Global Annual Medical Report

  • How FMCNA Increased the Understanding of COVID-19 | FMCNA
  • COVID-19 Associated Acute Kidney Injury | FMCNA
  • COVID-19 Vaccines: The Fight Against the Global Pandemic
  • Covid-19 Emerging Variants | FMCNA
  • Global Report of Covid-19 in End-Stage Kidney Disease
  • Optimizing CMS Guidelines for New Products | FMCNA
  • Connected Health at Fresenius Medical Care | FMCNA
  • Innovation and Transformation Through Partnerships
  • Critical Care at Fresenius Medical Care
  • Patient-Centered Care: A Framework for Global Quality Measurement | FMCNA
  • Improving Access to Kidney Transplantation | FMCNA
  • Patient-Centered Vascular Access Care | FMCNA
  • Shared Hemodialysis Care and the Patient Experience | FMCNA
  • Optimal Dialysis Start: Lessons Learned from Canada and the US | FMCNA
  • Global Clinical Research in the Era of Digital Health | FMCNA
  • Enhancing Clinical Trial Design with Patient-Reported Measures
  • Improving Care with Real-World Evidence | FMCNA
  • Cardiovascular Disease in Dialysis Patients in Latin America | FMCNA
  • Globalizing Medical Information and Education | FMCNA
  • The Right Drug for the Right Person | Precision Nephrology
  • Frenova Genomics Registry: Genomics and Precision Medicine
  • Cardiovascular Health in Chronic Kidney Disease | FMCNA
  • Fluid Management: Past, Present, and Future | FMCNA
  • Advancing Kidney Disease Care Through Scope, Scale & Equity
  • Has The Time Come To Rethink Dialysis Treatment Cadence?